FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, Dec 9, 2025
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on December 9, 2025, issued by the Cincinnati District Office, covering biologics.
View Company Profile
ID · e574ddcf-ecc7-43ab-8ab2-fe3780d03f71
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1295290
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
5- 21 CFR 606.160(b)Required records
- 21 CFR 606.65(e)Following manufacturer"s instructions
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 640.68(a)Separation
- 21 CFR 606.65(e)Following manufacturer's instructions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 15, 2023 | Not classified | Cincinnati District Office |
Other documents for Biomat USA Inc
- FDA Inspection 1211093 - 2023-06-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.